{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:15:44Z","timestamp":1791288944145,"version":"4.3.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Although airway microbiota composition correlates with clinical measures in non\u2013cystic fibrosis bronchiectasis, these data are unlikely to provide useful prognostic information at the individual patient level. A system enabling microbiota data to be applied clinically would represent a substantial translational advance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to determine whether stratification of patients according to the predominant microbiota taxon can provide improved clinical insight compared with standard diagnostics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The presence of bacterial respiratory pathogens was assessed in induced sputum from 107 adult patients by culture, quantitative PCR, and, in 96 samples, by ribosomal gene pyrosequencing. Prospective analysis was performed on samples from 42 of these patients. Microbiological data were correlated with concurrent clinical measures and subsequent outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Microbiota analysis defined three groups: Pseudomonas aeruginosa dominated (n = 26), Haemophilus influenzae dominated (n = 34), and other taxa dominated (n = 36). Patients with P. aeruginosa\u2013 and H. influenzae\u2013dominated communities had significantly worse lung function, higher serum levels of C-reactive protein (CRP), and higher sputum levels of IL-8 and IL-1\u03b2. Predominance of P. aeruginosa, followed by Veillonella species, was the best predictor of future exacerbation frequency, with H. influenzae\u2013dominated communities having significantly fewer episodes. Detection of P. aeruginosa was associated with poor lung function and exacerbation frequency, irrespective of analytical strategy. Quantitative PCR revealed significant correlations between H. influenzae levels and sputum IL-8, IL-1\u03b2, and serum CRP. Genus richness was negatively correlated with 24-hour sputum weight, age, serum CRP, sputum IL-1\u03b2, and IL-8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Stratification of patients with non\u2013cystic fibrosis bronchiectasis on the basis of predominant bacterial taxa is more clinically informative than either conventional culture or quantitative PCR\u2013based analysis. Further investigation is now required to assess the mechanistic basis of these associations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201310-335oc","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T18:14:39Z","timestamp":1393956879000},"page":"496-503","source":"Crossref","is-referenced-by-count":214,"title":["A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis"],"prefix":"10.1093","volume":"11","author":[{"given":"Geraint B.","family":"Rogers","sequence":"first","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland, and Translational Research Institute, Woolloongabba, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Masirah M.","family":"Zain","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Bruce","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, King\u2019s College London, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy D.","family":"Burr","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland, and Translational Research Institute, Woolloongabba, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Chen","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland, and Translational Research Institute, Woolloongabba, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian W.","family":"Rivett","sequence":"additional","affiliation":[{"name":"Division of Ecology and Evolution, Department of Life Sciences, Imperial College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"McGuckin","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland, and Translational Research Institute, Woolloongabba, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Serisier","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland, and Translational Research Institute, Woolloongabba, Queensland, Australia"},{"name":"Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"2026012303531088700_bib1","first-page":"6","article-title":"Inflammation: a two-edged sword\u2014the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"2026012303531088700_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non\u2013cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303531088700_bib3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1183\/09031936.96.09081601","article-title":"Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa","volume":"9","author":"Evans","year":"1996","journal-title":"Eur Respir J"},{"key":"2026012303531088700_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow-up study in adult bronchiectasis","volume":"101","author":"King","year":"2007","journal-title":"Respir Med"},{"key":"2026012303531088700_bib5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non\u2013cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"key":"2026012303531088700_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"Pasteur","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303531088700_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","article-title":"Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition","volume":"68","author":"Rogers","year":"2013","journal-title":"Thorax"},{"key":"2026012303531088700_bib8","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303531088700_bib9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non\u2013cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"2026012303531088700_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/JCM.01324-09","article-title":"Determining cystic fibrosis\u2013affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling","volume":"48","author":"Rogers","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2026012303531088700_bib11","year":"2010"},{"key":"2026012303531088700_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/ismej.2012.145","article-title":"Reducing bias in bacterial community analysis of lower respiratory infections","volume":"7","author":"Rogers","year":"2013","journal-title":"ISME J"},{"key":"2026012303531088700_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1462-2920.2010.02173.x","article-title":"Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa","volume":"12","author":"Klepac-Ceraj","year":"2010","journal-title":"Environ Microbiol"},{"key":"2026012303531088700_bib14","doi-asserted-by":"crossref","first-page":"e11044","DOI":"10.1371\/journal.pone.0011044","article-title":"Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients","volume":"5","author":"Cox","year":"2010","journal-title":"PLoS One"},{"key":"2026012303531088700_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/ismej.2010.175","article-title":"Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities","volume":"5","author":"van der Gast","year":"2011","journal-title":"ISME J"},{"key":"2026012303531088700_bib16","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.1120577109","article-title":"Decade-long bacterial community dynamics in cystic fibrosis airways","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012303531088700_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.tim.2013.03.004","article-title":"Interpreting infective microbiota: the importance of an ecological perspective","volume":"21","author":"Rogers","year":"2013","journal-title":"Trends Microbiol"},{"key":"2026012303531088700_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.00051-05","article-title":"Ventilator-associated pneumonia: diagnosis, treatment, and prevention","volume":"19","author":"Koenig","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"2026012303531088700_bib19","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JCM.02282-05","article-title":"Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis","volume":"44","author":"Rogers","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2026012303531088700_bib20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/314046","article-title":"Veillonella parvula meningitis: case report and review of Veillonella infections","volume":"31","author":"Bhatti","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2026012303531088700_bib21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1128\/jcm.34.5.1283-1285.1996","article-title":"Veillonella infections in children","volume":"34","author":"Brook","year":"1996","journal-title":"J Clin Microbiol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/11\/4\/496\/66485095\/annalsats_11_4_496.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/11\/4\/496\/66485095\/annalsats_11_4_496.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:53:27Z","timestamp":1769158407000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/11\/4\/496\/8431980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,5,1]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201310-335oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,5]]},"published":{"date-parts":[[2014,5,1]]}}}